What amount sold does PurCell Bio, Inc report in Form D filings?

The latest linked filings report $695K sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was PurCell Bio, Inc's most recent SEC filing?

PurCell Bio, Inc's most recent Form D filing was on 2024-01-25.

How many investors does PurCell Bio, Inc have?

The most recent Form D filing lists 25 investor(s).

What type of securities does PurCell Bio, Inc offer?

PurCell Bio, Inc's SEC Form D filings indicate equity offerings.

PurCell Bio, Inc

CIK: 0002001594·Biotechnology·BOZEMAN, MT·Corporation·Founded 2020

Reported Sold

$695,000

Total Filings

Identified Offerings

Last Filed

Jan 25, 2024

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Jan 25, 2024Form D — New notice

Reported sold: $695,000 · Target: $1,300,000

Rule 506(b)·25 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

No Revenues

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 1 identified offering

$695,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Elizabeth D Corbin

Related Person

Appears on 1 filing

Eric Jacobs

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Jan 25, 2024	New	$1,300,000	$695,000	25

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Alercell Inc

Biotechnology

Offering target: $1,500,000

Filed Oct 19, 2026